HCA Healthcare stock: October 27 earnings call covers HCA Healthcare stock
Published on 10/22/2026 at 15:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSScheduled earnings and valuation
- HCA Healthcare scheduled its third-quarter earnings call for October 27, 2026.
- Second-quarter revenue reached USD 20.23 billion, up 8.70 percent year over year.
- HCA Healthcare stock costs EUR 411.10 at Lang & Schwarz on October 22, 2026 at 3:30 p.m. CEST, 2.04 percent above the Frankfurt close.
- TD Cowen raised its target to USD 460.00 on October 12, 2026.
HCA Healthcare (ISIN US40412C1018) has scheduled its third-quarter 2026 earnings call for October 27, 2026, at 9:00 a.m. Central time, according to an official release dated September 30, 2026 from HCA Healthcare. Second-quarter revenue reached USD 20.23 billion, up 8.70 percent year over year, according to Yahoo Finance. At Lang & Schwarz, the stock was trading at EUR 411.10 on October 22, 2026 at 3:30 p.m. CEST, 2.04 percent above the Frankfurt close of October 20, 2026 at EUR 402.90.
Revenue sets the earnings backdrop
The second-quarter revenue figure exceeded analysts' expectations by 2.40 percent, while adjusted earnings per share reached USD 7.59, compared with a consensus estimate of USD 7.40. The figures give the October 27 call a clear operating benchmark: patient volumes and payer mix will be central to the next update.
Stock remains below its yearly high
On the NYSE, HCA Healthcare was last quoted at USD 460.87 on October 22, 2026 at 9:31 a.m. ET. The same quote placed the 52-week range at USD 353.99 to USD 556.52, leaving the stock 17.19 percent below its high and 30.19 percent above its low. Market capitalization stood at USD 99.8 billion, while the price-to-earnings ratio was 15.40.
What do analysts expect?
TD Cowen raised its price target from USD 431.00 to USD 460.00 and kept a Buy rating on October 12, 2026, according to Benzinga. The target is 0.19 percent below the NYSE quote. Benzinga also listed 22 analysts with an average consensus target of USD 477.00.
Comparison with peers
HCA Healthcare: 2.04 percent above the Frankfurt close, price-to-earnings ratio 15.40, market capitalization USD 99.8 billion
Tenet Healthcare (NYSE, USD): up 0.31 percent, price-to-earnings ratio 10.41, market capitalization USD 21.7 billion
Universal Health Services (NYSE, USD): up 0.16 percent, price-to-earnings ratio 7.51, market capitalization USD 10.8 billion
October 27 is the next date
The next scheduled corporate event is the third-quarter 2026 earnings call on October 27, 2026. Management's update will put the USD 20.23 billion second-quarter revenue base alongside the company's latest outlook.
Price and earnings date
The scheduled call gives investors a dated checkpoint, while the EUR 411.10 Lang & Schwarz quote stood above the Frankfurt close of October 20, 2026. The further course of trading is shown by the continuously updated real-time quote of HCA Healthcare stock.
HCA Healthcare stock at a glance
- Company: HCA Healthcare, Inc.
- ISIN: US40412C1018
- Ticker: HCA
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 22, 2026, 3:30 p.m. CEST): EUR 411.10
- Change versus Frankfurt close: plus 2.04 percent
- Frankfurt close (October 20, 2026): EUR 402.90
- Market capitalization: USD 99.8 billion (as of October 22, 2026)
- 52-week range: USD 353.99-556.52 (as of October 22, 2026)
- Sector / Industry: Healthcare / Medical - Care Facilities
- Next earnings date: October 27, 2026
Market context: Market report S&P 500.
